Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL

Blood

Volumn 111, Issue 12, 2008, Pages 5691-5693

  Crowther Swanepoel, Dalemari ^a   Wild, Ruth ^a   Sellick, Gabrielle ^a   Dyer, Martin J S ^b   Mauro, Francesca R ^c   Cuthbert, Robert J G ^d   Jonsson, Viggo ^e   Matutes, Estella ^f   Dearden, Claire ^f   Wiley, James ^g   Fuller, Stephen ^g   Catovsky, Daniel ^a   Houlston, Richard S ^a,h  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d BELFAST CITY HOSPITAL   (United Kingdom)

^e AKER UNIVERSITY HOSPITAL   (Norway)

^f ROYAL MARSDEN HOSPITAL   (United Kingdom)

^g UNIVERSITY OF SYDNEY   (Australia)

^h NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENOME ANALYSIS; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; B CELL LEUKEMIA; ENVIRONMENT; FAMILY HEALTH; GENETICS; MUTATION; PHENOTYPE;

ENVIRONMENT; FAMILY HEALTH; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MUTATION; PHENOTYPE;

EID: 47049089666     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-03-142349     Document Type: Article

References (15)

1. Shen A, Humphries C, Tucker P, Blattner F. Human heavy-chain variable region gene family nonrandomly rearranged in familial chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 1987;84:8563-8567.
2. Troussard X, Pritsch O, Marco M, et al. Do B-cell superantigens play a role in CLL leukaemogen-esis [abstract]? Blood. 1996;88:239a. Abstract 946.
3. Pritsch O, Troussard X, Magnac C, et al. VH gene usage by family members affected with chronic lymphocytic leukaemia. Br J Haematol. 1999;107: 616-624.
4. Sakai A, Marti G, Caporaso N, et al. Analysis of expressed immunoglobulin heavy chain genes in familial B-CLL. Blood. 2000;95:1413-1419.
5. Catovsky D, Richards S, Matutes E, et al. Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. Lancet. 2007;370:230-239.
6. Muller-Hermelink H, Montserrat E, Catovsky D, Harris N. Chronic lymphocytic leukaemia /small lymphocytic lymphoma. In: Jaffe ES; Harris NL Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press. 2001; 127-130.
7. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317.
8. van Krieken JH, LangerakAW, Macintyre EA, et al. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia. 2007;21:201-206.
9. International Immunogenetics Information System. http://imgt.cines.fr. Accessed October 31, 2007.
10. Tobin G, Thunberg U, Johnson A, et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood. 2003;101: 4952-4957.
11. Tobin G, Thunberg U, Karlsson K; et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood. 2004;104:2879-2885.
12. Cannon-Albright LA, Thomas A, Goldgar DE, et al. Familiality of cancer in Utah. Gancer Res. 1994;54:2378-2385.
13. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840-1847.
14. Bilous N, Abramenko I, Kryachok I, Bazyka D, Chumak A, Bebeshko V. Significance of VH genes mutation status for prognosis of CLL patients. Exp Oncol. 2005;27:325-329.
15. Rawstron AC, Yuille MR, Fuller J, et al. Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood. 2002;100:2289-2290.